TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs January 10, 1986
TCL Archive Administration’s FY 1981 Budget Would Leave Gaps, Curtail Many Program, Without New Cuts March 28, 1980
